Instituto de Investigación e Innovación en Ciencias Biomédicas (INiBICA)
Instituto de investigación
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (25)
2024
-
Association of obesity on the outcome of critically ill patients affected by COVID-19
Medicina Intensiva, Vol. 48, Núm. 3, pp. 142-154
2023
-
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients
Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study
Scientific reports, Vol. 13, Núm. 1, pp. 6553
-
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study
Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 7, pp. 725-735
2022
-
Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
Journal of Critical Care, Vol. 69
-
Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients
Journal of Infection, Vol. 85, Núm. 4, pp. 374-381
2021
-
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Annals of Intensive Care, Vol. 11, Núm. 1
-
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
Critical Care, Vol. 25, Núm. 1
-
Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA index
Contact Dermatitis, Vol. 84, Núm. 6, pp. 395-406
-
Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study
The Lancet Regional Health - Europe, Vol. 11
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2020
-
Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 650-654
2019
-
Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015)
Contact Dermatitis, Vol. 80, Núm. 2, pp. 94-100
2018
-
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study
Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82
-
Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697
2017
-
Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study
Contact Dermatitis, Vol. 76, Núm. 2, pp. 74-80
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558